MarketCap
Arcutis Biotherapeutics ARQT
$ 28.37
3.35%
Facebook
X
Telegram
Country |
 USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
127 M |
Market Cap[1] |
$ 3.61 B |
EBITDA (LTM) |
$ 36.9 M |
P/E (LTM) |
155.590909 |
P/S (LTM) |
8.595585 |
EPS (LTM) |
0.22 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.68 | 0.57 % | $ 779 M | Nasdaq Global Select Market | USA |
 |
Processa Pharmaceuticals
PCSA
|
$ 1.85 | -1.07 % | $ 2.42 M | Nasdaq Global Select Market | USA |
 |
Eton Pharmaceuticals
ETON
|
$ 68.4 | 1.27 % | $ 1.84 B | Nasdaq Global Market | USA |
 |
IDEAYA Biosciences
IDYA
|
$ 32.71 | 3.02 % | $ 2.89 B | Nasdaq Global Select Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 3.13 | 9.44 % | $ 246 M | NYSE American |  Israel |
 |
Lantern Pharma
LTRN
|
$ 0.47 | 1.53 % | $ 5.12 M | Nasdaq Global Select Market | USA |
 |
Foghorn Therapeutics
FHTX
|
$ 2.04 | 7.37 % | $ 128 M | Nasdaq Global Market | USA |
 |
Ocugen
OCGN
|
$ 0.96 | 0.8 % | $ 300 M | Nasdaq Capital Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.42 | 9.19 % | $ 40.3 M | Nasdaq Global Select Market |  Canada |
 |
Minerva Neurosciences
NERV
|
$ 2.56 | 2.81 % | $ 21.7 M | Nasdaq Global Market | USA |
 |
Kamada Ltd.
KMDA
|
$ 8.1 | 0.43 % | $ 467 M | Nasdaq Global Select Market | Israel |
 |
Neurocrine Biosciences
NBIX
|
$ 173.86 | 2.79 % | $ 17.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 32.73 | 0.03 % | $ 1.57 T | Nasdaq Global Select Market |  France |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.31 | 2.89 % | $ 247 M | Nasdaq Global Select Market |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
$ 7.71 | -1.91 % | $ 1.11 B | Nasdaq Global Select Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 1.86 | 1.34 % | $ 675 M | Nasdaq Global Select Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 8.05 | -0.12 % | $ 9.54 M | Nasdaq Global Select Market | USA |
 |
Nurix Therapeutics
NRIX
|
$ 16.46 | 3.65 % | $ 1.43 B | Nasdaq Global Select Market,SPB | USA |
 |
Nkarta
NKTX
|
$ 1.49 | 10.0 % | $ 110 M | Nasdaq Global Select Market | USA |
 |
MacroGenics
MGNX
|
$ 2.33 | -3.85 % | $ 147 M | Nasdaq Global Select Market | USA |
 |
Protagonist Therapeutics
PTGX
|
$ 134.78 | -1.06 % | $ 8.57 B | Nasdaq Global Select Market | USA |
|
Nuvation Bio
NUVB
|
$ 4.3 | 2.26 % | $ 1.47 B | NYSE | USA |
 |
Novo Nordisk A/S
NVO
|
$ 41.06 | 0.88 % | $ 182 B | NYSE |  Danmark |
 |
Marker Therapeutics
MRKR
|
$ 0.95 | 0.07 % | $ 14.5 M | Nasdaq Global Market | USA |
 |
NextCure
NXTC
|
$ 6.3 | 5.35 % | $ 33.5 M | Nasdaq Global Select Market | USA |
 |
Rocket Pharmaceuticals
RCKT
|
$ 2.47 | 0.82 % | $ 274 M | Nasdaq Global Select Market | USA |
 |
PMV Pharmaceuticals
PMVP
|
$ 1.25 | 2.87 % | $ 65.7 M | Nasdaq Global Select Market | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 8.16 | 12.24 % | $ 710 M | Nasdaq Global Select Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 135.02 | -1.19 % | $ 11.4 B | Nasdaq Global Market | USA |
 |
Oragenics
OGEN
|
$ 0.35 | 1.4 % | $ 755 K | NYSE American | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.77 | -1.07 % | $ 361 M | Nasdaq Global Select Market | USA |
 |
Passage Bio
PASG
|
$ 3.91 | 3.44 % | $ 12.5 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 68.44 | 3.13 % | $ 9.31 B | Nasdaq Global Select Market | USA |
 |
Relay Therapeutics
RLAY
|
$ 19.87 | -0.35 % | $ 3.41 B | Nasdaq Global Market | USA |
 |
Precigen
PGEN
|
$ 4.75 | 4.98 % | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
Avidity Biosciences
RNA
|
$ 7.97 | -3.22 % | $ 1.1 B | Nasdaq Global Select Market | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.81 | -0.07 % | $ 4.85 M | Nasdaq Capital Market | USA |
 |
Spero Therapeutics
SPRO
|
$ 1.02 | 1.49 % | $ 57.1 M | Nasdaq Global Select Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 346.47 | 2.63 % | $ 7.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 3.8 | 1.06 % | $ 292 M | Nasdaq Global Select Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.26 | -3.82 % | $ 133 M | Nasdaq Global Market |  Niderland |
 |
Ocular Therapeutix
OCUL
|
$ 6.66 | 0.68 % | $ 1.25 B | Nasdaq Global Select Market | USA |
 |
PolyPid Ltd.
PYPD
|
$ 6.56 | 3.96 % | $ 107 M | Nasdaq Global Select Market | Israel |
 |
Outlook Therapeutics
OTLK
|
$ 0.48 | 4.34 % | $ 16.7 M | Nasdaq Global Select Market | USA |
 |
uniQure N.V.
QURE
|
$ 24.64 | 8.5 % | $ 1.42 B | Nasdaq Global Select Market | Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 16.7 | 3.44 % | $ 1.65 B | Nasdaq Global Select Market,SPB | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 16.67 | 1.4 % | $ 1.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Rafael Holdings
RFL
|
$ 1.12 | 4.67 % | $ 57.6 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 8.57 | 11.38 % | $ 442 M | Nasdaq Global Select Market,SPB | USA |
 |
Rigel Pharmaceuticals
RIGL
|
$ 44.17 | 0.58 % | $ 794 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.